TrialCancer communications (London, England)2018

Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial.

Fulong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.